Meet Mahesh Karande, President and CEO of Omega Therapeutics. Explaining epigenetics and his vision of directing the human genome to treat and cure serious diseases, including lung cancer.

Written By Dave Bjork

Another amazing human.

On today's episode, meet Mahesh Karande. Mahesh is President and CEO of Omega Therapeutics, a clinical stage biotechnology company in Cambridge, Mass. Mahesh is deeply experienced in running biopharma businesses across discovery, preclinical and clinical development, and commercialization.  Earlier, Mr. Karande spent several years at Novartis in senior leadership roles: VP and Head of US Oncology for solid tumors, President of Novartis Africa and President of Novartis Egypt. Mr. Karande has an M.B.A. from the Wharton School, University of Pennsylvania, an M.S. in engineering from Georgia Institute of Technology, and undergrad degree in engineering from the University of Bombay. Leading a company with an overarching ethos to be ambitious, yet humble.

 
 
Dave Bjork
Previous

Meet Chyke Doubeni, MD, MPH, Chief Health Equity Officer at The Ohio State University Wexner Medical Center. Leading Ohio State's efforts to address underlying drivers of disparities in health care.
Next

Meet Dr. Sumita Bhatta. Medical oncologist and Vice President, Global Medical Affairs Head of Oncology at Amgen. Commitment to patients is at the center of her work.